MedTrace Logo

Quantitative Magnetic Resonance Imaging in Biliary Disease: Health Economics Study

NCT04015310 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2021-07-21

No results posted yet for this study

Summary

This is a health economic study on using quantitative magnetic resonance imaging in biliary disease. It is an observational study aiming to recruit 40 patients with Primary Sclerosing Cholangitis (PSC) in 12 months. The aim of the study is to assess the effect of result of enhanced Magnetic Resonance Cholangiopancreatography (MRCP+) on the physicians' diagnosis and/or plans for patients with suspected or confirmed PSC, compared with usual standard of care. This study also aims to identify the cost-effectiveness of adding MRCP+ to the standard care pathway.

Conditions

  • Primary Sclerosing Cholangitis
  • PSC

Interventions

DEVICE

Quantitative Multi parametric MRI and enhanced MRCP

Patients will have quantitative MRI and enhanced MRCP on addition to their standard of care

Sponsors & Collaborators

  • University of Birmingham

    collaborator OTHER

  • Perspectum

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-21
Primary Completion
2021-03-31
Completion
2021-03-31
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04015310 on ClinicalTrials.gov